Back
Top 0.9%
11.9%
Top 0.7%
11.9%
Top 8%
11.1%
Top 0.6%
6.5%
Top 0.9%
6.5%
Top 37%
6.5%
Top 2%
6.0%
Top 2%
3.9%
Top 1%
2.0%
Top 0.6%
2.0%
Top 1%
2.0%
Top 92%
2.0%
Top 7%
1.6%
Top 2%
1.6%
Top 2%
1.3%
Top 0.2%
1.3%
Top 0.4%
1.2%
Top 62%
1.0%
Top 10%
1.0%
Top 5%
0.7%
Top 17%
0.7%
Top 3%
0.5%
Top 19%
0.5%
Baseline Serum Metabolites as Predictors of Teplizumab Response in Individuals with Type 1 Diabetes
2025-12-23
endocrinology
Title + abstract only
View on medRxiv
Show abstract
Aims/hypothesisImmunotherapies such as Teplizumab can preserve residual beta cell function in individuals with newly diagnosed type 1 diabetes (T1D), but treatment response is variable. Currently, no biomarker exists to identify individuals most likely to benefit from immunotherapy. We believe that baseline serum metabolomic profiles can distinguish individuals who respond to treatment from nonresponders and predict therapeutic response. MethodsBaseline serum samples from 41 individuals newly d...
Predicted journal destinations
1
The Journal of Clinical Endocrinology & Metabolism
26 training papers
2
eLife
262 training papers
3
Nature Communications
483 training papers
4
Diabetologia
23 training papers
5
Frontiers in Endocrinology
20 training papers
6
Scientific Reports
701 training papers
7
BMC Medicine
155 training papers
8
JCI Insight
63 training papers
9
eBioMedicine
82 training papers
10
Communications Medicine
63 training papers
11
Cell Reports Medicine
49 training papers
12
PLOS ONE
1737 training papers
13
Frontiers in Immunology
140 training papers
14
International Journal of Molecular Sciences
39 training papers
15
eClinicalMedicine
55 training papers
16
EMBO Molecular Medicine
15 training papers
17
Med
26 training papers
18
BMJ Open
553 training papers
19
iScience
74 training papers
20
Nutrients
43 training papers
21
Nature Medicine
88 training papers
22
International Journal of Obesity
17 training papers
23
Open Forum Infectious Diseases
124 training papers